Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%
The company plans to submit authorization filing to the US FDA before Thanksgiving, Pfizer CEO Albert Bourla said.
THOUGH PRIME MINISTER Benjamin Netanyahu has touted his close relationship with Pfizer CEO Albert Bourla (on April 23), Levy was the one to sign the first contract for eight million doses.(photo credit: JOHN THYS/POOL VIA REUTERS)ByREUTERS
